Millennium Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51.8M Sell
1,408,853
-207,412
-13% -$9.83M 0.02% 807
2025
Q4
$82.2M Buy
1,616,265
+1,592,362
+6,662% +$81.4M 0.03% 515
2025
Q3
$1.33M Sell
23,903
-11,758
-33% -$688K ﹤0.01% 4395
2025
Q2
$2.46M Sell
35,661
-852,026
-96% -$58M ﹤0.01% 3694
2025
Q1
$61.6M Buy
887,687
+532,472
+150% +$44M 0.03% 621
2024
Q4
$30.6M Sell
355,215
-354,249
-50% -$38.3M 0.01% 1168
2024
Q3
$84.5M Sell
709,464
-1,456,141
-67% -$194M 0.04% 517
2024
Q2
$309M Buy
2,165,605
+1,852,828
+592% +$246M 0.14% 102
2024
Q1
$40.2M Sell
312,777
-669,637
-68% -$79.7M 0.02% 975
2023
Q4
$102M Buy
982,414
+624,805
+175% +$61.8M 0.04% 419
2023
Q3
$32.5M Sell
357,609
-856,065
-71% -$75.4M 0.02% 1033
2023
Q2
$98.2M Buy
1,213,674
+190,546
+19% +$15.6M 0.05% 369
2023
Q1
$81.4M Sell
1,023,128
-3,039,978
-75% -$216M 0.05% 422
2022
Q4
$275M Buy
4,063,106
+2,233,160
+122% +$131M 0.15% 84
2022
Q3
$91.2M Sell
1,829,946
-713,782
-28% -$38.2M 0.05% 373
2022
Q2
$142M Buy
2,543,728
+2,193,128
+626% +$122M 0.09% 159
2022
Q1
$19.5M Sell
350,600
-129,446
-27% -$6.64M 0.01% 1426
2021
Q4
$26.9M Sell
480,046
-1,098,738
-70% -$59.5M 0.01% 1187
2021
Q3
$75.8M Buy
1,578,784
+1,554,634
+6,437% +$75.2M 0.05% 422
2021
Q2
$1.01M Sell
24,150
-678,668
-97% -$26.3M ﹤0.01% 4654
2021
Q1
$23.7M Buy
+702,818
New +$25M 0.02% 964
2020
Q2
Sell
-184,714
Closed -$5.89M 4462
2020
Q1
$5.56M Sell
184,714
-1,523,972
-89% -$45.4M 0.01% 1260
2019
Q4
$49.4M Buy
1,708,686
+832,276
+95% +$23M 0.06% 368
2019
Q3
$22.7M Sell
876,410
-272,912
-24% -$6.9M 0.04% 705
2019
Q2
$29.3M Sell
1,149,322
-364,362
-24% -$9M 0.04% 573
2019
Q1
$39.6M Sell
1,513,684
-143,858
-9% -$3.54M 0.06% 429
2018
Q4
$38.2M Buy
1,657,542
+532,052
+47% +$11.8M 0.06% 437
2018
Q3
$26.5M Buy
1,125,490
+872,154
+344% +$21.3M 0.03% 690
2018
Q2
$5.84M Buy
253,336
+151,912
+150% +$3.61M 0.01% 1703
2018
Q1
$2.5M Sell
101,424
-565,874
-85% -$14.9M ﹤0.01% 2184
2017
Q4
$17.9M Buy
667,298
+505,688
+313% +$12.9M 0.02% 974
2017
Q3
$3.89M Sell
161,610
-344,250
-68% -$7.78M 0.01% 1808
2017
Q2
$10.8M Sell
505,860
-3,385,460
-87% -$68.3M 0.02% 1007
2017
Q1
$66.7M Buy
3,891,320
+3,835,260
+6,841% +$66.8M 0.12% 226
2016
Q4
$1M Sell
56,060
-3,014,014
-98% -$54.6M ﹤0.01% 2245
2016
Q3
$63.8M Buy
3,070,074
+2,724,698
+789% +$67.6M 0.11% 196
2016
Q2
$9.29M Buy
345,376
+40,586
+13% +$1.11M 0.02% 891
2016
Q1
$8.26M Buy
+304,790
New +$8.17M 0.02% 949
2015
Q4
Sell
-355,064
Closed -$9.83M 3673
2015
Q3
$9.63M Sell
355,064
-476,410
-57% -$13.5M 0.02% 951
2015
Q2
$22.8M Buy
+831,474
New +$23.4M 0.04% 568
2015
Q1
Sell
-1,161,092
Closed -$24.6M 3938
2014
Q4
$24.6M Buy
+1,161,092
New +$25.9M 0.05% 515
2014
Q3
Sell
-17,000
Closed -$393K 3909
2014
Q2
$393K Sell
17,000
-201,246
-92% -$4.44M ﹤0.01% 2732
2014
Q1
$4.98M Buy
218,246
+108,616
+99% +$2.31M 0.01% 1216
2013
Q4
$2.03M Sell
109,630
-246,750
-69% -$4.3M 0.01% 1817
2013
Q3
$6.03M Buy
356,380
+308,520
+645% +$5.19M 0.02% 1005
2013
Q2
$742K Buy
+47,860
New +$797K ﹤0.01% 2121

Other funds holding NVO

Millennium Management's NVO Position: Q1 2026 in Review

Millennium Management reduced its Novo Nordisk (NVO) stake by 13% in Q1 2026, selling an estimated $9.83M and leaving 1,408,853 shares worth $51.8M. The position accounts for 0.02% of the portfolio, ranked #807.

Millennium Management first reported a position in NVO in Q2 2013 and has held it in 46 quarters since. The position peaked at $309M in Q2 2024. 1,270 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Millennium Management held 1,408,853 shares of Novo Nordisk worth $51.8M as of Q1 2026.
  • Millennium Management sold 207,412 Novo Nordisk shares in Q1 2026, an estimated $9.83M.
  • Novo Nordisk made up 0.02% of Millennium Management's portfolio in Q1 2026, its #807 holding.
  • Millennium Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 46 quarters since.
  • Millennium Management's Novo Nordisk position peaked at $309M in Q2 2024.
  • 1,270 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.